Biliary Cancer: Current Multimodality Treatment and Future Directions

Area of Science:

• Oncology
• Gastroenterology

Background:

• Biliary cancer is a highly aggressive malignancy with increasing global incidence.
• Late-stage diagnosis is common due to subtle early symptoms, limiting curative treatment options.
• Current therapies offer poor outcomes, highlighting an unmet need for novel approaches.

Purpose of the Study:

• To review the current landscape of biliary cancer treatment.
• To emphasize the need for innovative therapeutic strategies.
• To explore the potential of next-generation sequencing in understanding and treating biliary cancer.

Main Methods:

• Literature review of biliary cancer incidence, diagnosis, and treatment.
• Analysis of surgical and systemic therapy outcomes.
• Discussion of advancements in molecular understanding through next-generation sequencing.

Main Results:

• Biliary cancer is frequently diagnosed at advanced or metastatic stages.
• Curative treatment is possible in only about one-third of patients, with a median survival under 24 months.
• Surgery offers curative potential in early stages, while systemic therapies show limited efficacy in advanced disease.

Conclusions:

• There is a critical need for novel therapeutic strategies in biliary cancer.
• Next-generation sequencing offers promise for uncovering the molecular underpinnings of biliary cancer.
• Targeted therapies based on molecular profiling may represent future treatment avenues.